BREAKING: National Institute Integrates Plant-Based Diet To Treat T2 Diabetes

by health and nutrition advice journalist

The prevailing belief among lay people has long been that people with diabetes should avoid carbs. In fact, the most common nutritional approach to managing the disease has diabetics counting – and limiting – foods that are high in carbohydrates.

But the Natural Food Interaction (NFI) diet, a new plant-based approach specifically designed to treat type 2 diabetes, appears to flip this conventional wisdom on its head, claims co-founder and biomedical scientist Zuzana Plevova.

According to Plevova, the initial pilot study results were so impressive that, when presented to an acclaimed European diabetes researcher, Dr. Emil Martinka MD PhD, he jumped at the opportunity to conduct a larger study on 100 people to assess the effects of the new diet, which started last week.

What is the NFI diet?

The Natural Food Interaction diet is a whole food, plant-based approach that goes one step further, says Plevova, by creating a personalized diet plan based on mixing and matching different plant foods in combinations that are said to provide powerful physiological effects. “We have looked at the interactions of specific foods that help the body attack the lipid saturation, or accumulation of fat found in the cells of people with diabetes.

“The diet was designed to be personalized based on a variety of characteristics that different people have. Up to 3 million different eating plans can be constructed to custom-make a tailored plan to target the specific needs of each individual.”

Early pilot studies showed dramatic reversals in patients who have suffered from diabetes for as long as 29 years, Plevova claims. “Patients have gone into remission, along with experiencing weight loss, and dramatic improvements in cholesterol, blood pressure, triglycerides, and hypertension.”

She says that they are also in talks with the National Health Service in the UK as well as healthcare providers in Germany about conducting further clinical trials.

More to follow.

This content was originally published here.

Share this article

Leave a comment

Your email address will not be published. Required fields are marked *